Literature DB >> 3443226

Feeding rats diets containing cheno- or ursodeoxycholic acid or cholestyramine modifies intestinal uptake of glucose and lipids.

A B Thomson1, M Keelan.   

Abstract

We wished to test the hypothesis that variations in the luminal content of bile acid produced by feeding chenodeoxycholic acid (CDC), ursodeoxycholic acid (UDC) or cholestyramine (C) alter intestinal transport properties and morphology. Rats were fed standard chow pellets containing 0.5% CDC, 0.5% UDC or 2% C for a period of 2 weeks, and the in vitro uptake of glucose, cholesterol, bile acids and a homologous series of fatty acids was assessed. The food consumption was similar in animals fed chow, CDC, UDC and C, yet rats fed CDC or UDC gained less weight, and the weight of the jejunal and ileal mucosa was lower in animals fed CDC or C than in those fed chow or UDC. Ileal but not jejunal uptake of glucose was reduced in animals fed UDC, CDC or C. The active ileal uptake of bile acids was enhanced by UDC, CDC or C, whereas the jejunal passive permeability to bile acids was reduced by feeding C. Feeding C inhibited the jejunal and ileal uptake of cholesterol; C, UDC and CDC had a variable effect on the intestinal uptake of the fatty acids 10:0-18:0. The jejunal mucosal surface area was lower in groups fed CDC or UDC as compared with rats fed chow or C, and the ileal mucosal surface area was lower in rats fed CDC. However, the altered intestinal transport could not be explained by the altered morphology. Thus, (1) chronic variations in the intestinal luminal content of bile acids produced by the feeding of CDC, UDC or C resulted in alterations in the active and passive transport properties of the intestine, and (2) these changes differed between the jejunum and the ileum and were not explained simply by alterations in the animals' food intake or mucosal morphology. These studies suggest that chronic variations in the bile acids in the intestinal lumen may be one of the factors independently influencing the transport properties and mucosal surface area of the intestine. The long-term effect of changes in luminal bile acid content on intestinal function in man remains to be established.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3443226     DOI: 10.1159/000199586

Source DB:  PubMed          Journal:  Digestion        ISSN: 0012-2823            Impact factor:   3.216


  5 in total

1.  Characterization of cardiovascular outcomes in a type 2 diabetes glucose supply and insulin demand model.

Authors:  Scott V Monte; Jerome J Schentag; Martin H Adelman; Joseph A Paladino
Journal:  J Diabetes Sci Technol       Date:  2010-03-01

2.  Cholestyramine alters the lipid and energy metabolism of chicks fed dietary medium- or long-chain triacylglycerol.

Authors:  R T Mabayo; M Furuse; A Murai; J Okumura
Journal:  Lipids       Date:  1995-09       Impact factor: 1.880

Review 3.  Bile acid sequestrants: glucose-lowering mechanisms and efficacy in type 2 diabetes.

Authors:  Morten Hansen; David P Sonne; Filip K Knop
Journal:  Curr Diab Rep       Date:  2014       Impact factor: 4.810

Review 4.  Bile acid sequestrants and the treatment of type 2 diabetes mellitus.

Authors:  Bart Staels; Folkert Kuipers
Journal:  Drugs       Date:  2007       Impact factor: 9.546

5.  Improving glycemic and cholesterol control through an integrated approach incorporating colesevelam - a clinical perspective.

Authors:  Ronald B Goldberg
Journal:  Diabetes Metab Syndr Obes       Date:  2009-05-05       Impact factor: 3.168

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.